CytomX Therapeutics Inc. (($CTMX)) has held its Q3 earnings call. Read on for the main highlights of the call. CytomX Therapeutics Inc. recently ...

CX-2051 Phase 1 data update on track for Q1 2026 - - CX-2051 Phase 1b CRC combination study with bevacizumab to start in Q1 2026 - - Positive CX-801 Phase 1 monotherapy biomarker data at SITC 2025 ...

Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Good afternoon, everyone. Thank you for standing by. Welcome to ...

That's right... the CarBuzz spy photo team has captured a Mazda test mule being put through its paces near the Japanese ...

PALO ALTO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Talkdesk®, Inc. today announced the winners of its sixth annual CX Innovators Awards. The awards program recognizes companies that have uniquely ...

Darwin CX, the Canadian-born leader in customer experience and subscription management software for media companies, pairs ...

Lease the 2026 Hyundai Tucson from $269/month with $3,999 down. Full trim pricing, terms, and key features. Offers end ...

Customer backlash to AI-powered vehicle scans this summer did not deter AI investments in the company’s customer service ...

Despite a significant drop in revenue, CytomX Therapeutics Inc (CTMX) advances its oncology pipeline with promising clinical ...

HIGHS Upscale interior, sprightly plug-in hybrid powertrain, athletic handling for a three-row SUV. LOWS Native infotainment still needs simplification, tight third row, awkward shifter and odd ...

HIGHS Zesty handling, powerful turbocharged engine option, class-above cabin environs. LOWS Some rivals offer more passenger space, the most desirable trims and features amp up the price, basic ...